Allergen-specific immunotherapy in the treatment of allergic diseases
- 作者: Varfolomeeva M.I.1, Kulagina I.T.1, Zaitsev A.A.1
-
隶属关系:
- The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
- 期: 卷 344, 编号 6 (2023)
- 页面: 44-49
- 栏目: Treatment and prophylactic issues
- URL: https://journals.eco-vector.com/0026-9050/article/view/630157
- DOI: https://doi.org/10.52424/00269050_2023_344_6_44
- ID: 630157
如何引用文章
详细
The role and necessity of allergen-specific immunotherapy in the treatment of allergic diseases such as allergic rhinitis, conjunctivitis, bronchial asthma, etc. is shown. A list of indications and contraindications for treatment is given. The key indication for allergen-specific immunotherapy is the presence of a proven IgE-dependent nature of the disease, as well as an established causal relationship between the allergens used and the allergic disease. The paper compares various methods of allergen-specific immunotherapy, considers its mechanism of action, safety and efficacy.
作者简介
M. Varfolomeeva
The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
编辑信件的主要联系方式.
Email: mvarf@yandex.ru
кандидат медицинских наук
俄罗斯联邦, MoscowI. Kulagina
The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: mvarf@yandex.ru
кандидат медицинских наук
俄罗斯联邦, MoscowA. Zaitsev
The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: a-zaicev@yandex.ru
заслуженный врач РФ, профессор, полковник медицинской службы
俄罗斯联邦, Moscow参考
- Гущин И.С. Аллергическое воспаление и его фармакологический контроль. – М.: Фармарус принт., 1998. – 251 с.
- Гущин И.С., Курбачева О.М. Аллерген-специфическая иммунотерапия атопических заболеваний: Пособие для врачей. – М., 2002. – 32 с.
- Гущин И.С., Курбачева О.М. Аллергия и аллерген-специфическая иммунотерапия. – М.: Фармарус Принт Медиа, 2010. – 228 с.
- Курбачева О.М. Клинические, патогенетические и экономические аспекты применения аллерген-специфической иммунотерапии: Дис. ... д-ра мед. наук. – М., 2007. – 198 с.
- Курбачева О.М., Павлова К.С. Оценка клинической эффективности аллерген-специфической иммунотерапии при лечении больных атопическими респираторными заболеваниями // Физиол. и патол. иммунной системы. – 2005. – № 5. – С. 3–6.
- Курбачева О.М., Павлова К.С., Шульженко А.Е. Безопасность аллерген-специфической иммунотерапии // Пульмонология. – 2006. – № 2. – С. 38–43.
- Пичужкина О.В., Гущин И.С., Курбачева О.М. Реаранжировка иммунного ответа в результате проведения аллергенспецифической иммунотерапии // Иммунология. – 2013. – № 1. – С. 43–48.
- Akdis M., Akdis C.A. Mechanisms of allergen-specific immunotherapy // J. Allergy Clin. Immunol. – 2007. – Vol. 119. – P. 780–789.
- Akdis C.A., Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells // J. Allergy Clin. Immunol. – 2009. – Vol. 123. – P. 735–746.
- Akdis M., Schmidt-Weber C., Jutel M. et al. Mechanisms of allergen immunotherapy // Clin. Exp. Allergy. – 2004. – Vol. 4. – Р. 56–60.
- Bantz S.K., Zhu Z., Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma // J. Clin. Cell. Immunol. – 2014. – Vol. 5, Iss. 2. – P. 1–8
- Bousquet J., Lockey R., Malling H.J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper // J. Allergy Clin. Immunol. – 1998. – Vol. 102, N 4 – P. 558–562.
- Calderon M.A., Alves B., Jacobson M. et al. Allergen injection immunotherapy for seasonal allergic rhinitis // Cochrane Database Syst. Rev. – 2007, Release 1.
- Deichmann K.A., Starke B., Schlenther S. et al. Linkage and association studies of atopy and the chromosome 11q13 region // J. med. genetics. – 1999. – Vol. 36, N 5 – P. 379–382.
- Jutel M., Agache I., Bonini S. et al. International consensus on allergy immunotherapy // J. Allergy Clin. Immunol. – 2015 – Vol. 136, N 3. – P. 556–568.
- Jutel M., Akdis C.A. Immunological mechanisms of allergen-specific immunotherapy // Allergy. – 2011. – Vol. 66, N 6. – P. 725–732.
- Khinchi M.S., Poulsen L.K., Carat F. et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study // Allergy. – 2004. – Vol. 59. – P. 45–53.
- March M.E., Sleiman P.M., Hakonarson H. The genetics of asthma and allergic disorders // Discov. med. – 2011. – Vol. 11, N 56. – P. 35–45.
- Nelson H., Cartier S., Allen-Ramey F. et al. Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy // J. Allergy Clin. Immunol. Pract. – 2015. – Vol. 3. – P. 256–266.
- Normansell R., Kew K.M., Bridgman A.L. Sublingual immunotherapy for asthma // Cochrane Database Syst. Rev. – 2015. – Vol. 28, Release 8.
- Ozdemir C. An immunological overview of allergen specific immunotherapy – subcutaneous and sublingual routes // Ther. Adv. Resp. dis. – 2009. – Vol. 3. – N 5. – P. 253–262.
- Ozdemir C., Akdis M., Akdis C.A. Nature of regulatory T cells in the context of allergic disease // Allergy Asthma Clin. Immunol. – 2008. – Vol. 15. – P. 106–110.
- Radulvic S., Calderon M.A., Wilson D., Durham S. Sublingual immunotherapy for allergic rhinitis // Cochrane database Syst. Rev. – 2010. – Vol. 8, Release 12.